Dolby Laboratories
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $315,546 | $369,561 | $356,999 | $304,806 |
Gross Profit | 271,544 | 333,724 | 316,225 | 270,810 |
EBITDA | 136,400 | 110,293 | 59,734 | |
EBIT | 111,973 | 85,096 | 45,064 | |
Net Income | 46,071 | 91,793 | 67,822 | 58,570 |
Net Change In Cash | 315,546 | 369,561 | 356,999 | 304,806 |
Free Cash Flow | 61,263 | 168,000 | 100,000 | 108,791 |
Cash | 698,566 | 626,551 | 520,821 | 577,752 |
Basic Shares | 95,782 | 97,471 | 97,147 | 96,593 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $1,273,721 | $1,009,182 | $1,253,793 | $1,281,256 |
Gross Profit | 1,133,225 | 892,168 | 1,112,433 | 1,151,231 |
EBITDA | 258,326 | 219,247 | 329,905 | 464,117 |
EBIT | 170,999 | 219,247 | 206,605 | 344,390 |
Net Income | 360,642 | 191,470 | 184,087 | 310,227 |
Net Change In Cash | 1,273,721 | 1,009,182 | 1,253,793 | 1,281,256 |
Cost of Revenue | -587,917 | 153,053 | ||
Free Cash Flow | 297,245 | 259,912 | 259,120 | 393,299 |
Cash | 482,047 | 745,364 | 620,127 | 1,225,380 |
Basic Shares | 97,325 | 97,588 | 101,983 | 104,622 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.78 |
2025-03-31 | $1.34 |
2024-12-31 | $1.14 |
